Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 9,041 | 14,018 | 0 | 0 | 0 |
| Gross Profit | 9,041 | 14,018 | N/A | N/A | N/A |
| Operating Expenses | 314,841 | 123,548 | 36,901 | 25,204 | 12,261 |
| Operating Income | -305,800 | -109,530 | -36,901 | -25,204 | -12,261 |
| Interest Expense | 0 | 0 | 0 | 10 | 38 |
| Other Income | 12,837 | 2,724 | 5 | 503 | -5,538 |
| Pre-tax Income | -292,963 | -106,806 | -36,896 | -24,711 | -17,837 |
| Net Income Continuous | -292,963 | -106,806 | -36,896 | -24,711 | -17,837 |
| Net Income | $-292,963 | $-106,806 | $-36,896 | $-24,711 | $-17,837 |
| EPS Basic Total Ops | -5.00 | -5.38 | -3.09 | -2.14 | -5.26 |
| EPS Basic Continuous Ops | -5.00 | -5.38 | -3.04 | -2.14 | -5.26 |
| EPS Diluted Total Ops | -5.00 | -5.38 | -3.09 | -2.14 | -5.26 |
| EPS Diluted Continuous Ops | -5.00 | -5.38 | -3.04 | -2.14 | -5.26 |
| EPS Diluted Before Non-Recurring Items | -2.40 | -1.31 | -3.09 | -2.14 | -3.62 |
| EBITDA(a) | $-306,597 | $-109,314 | $-36,270 | $-24,449 | $-11,506 |